SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.51-1.3%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ian@SI who wrote (32955)11/21/2009 10:23:07 PM
From: fred hayes  Read Replies (1) of 52153
 
thanks for posting that. Very interesting, but very confusing to me. It would be cool if MS is caused by a correctable blood flow problem. The article seems to imply almost all MS is caused by the blood flow issue (my reading of para 4). I can't reconcile that with the fact that drugs aimed at the immune system have a clinically proven effect on MS. E.g., tysabri has shown to reduce attacks by something like two-thirds. Can someone comment on how to reconcile the blood flow theory with the effectiveness of immune system drugs? How can they both be valid?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News